Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Additions at Ezose; Board Changes at HealthLinx

Premium

Ezose Sciences this week named Scott Siegel its chief operating officer, a newly created position at the company.

Siegel was previously vice president of business development at the company. Before that he was vice president of corporate development for Redpoint Bio and before that held several positions in business development and marketing at Johnson & Johnson.

Ezose also named Diane McCarthy its director of scientific affairs as well as hired Ezra Jennings as senior scientist and Joshua Alfaro as scientist.


HealthLinx announced the resignations from its board of non-executive directors Stewart Washer and John Chiplin.

Washer joined HealthLinx's board in 2008 and Chiplin in 2010. The company said it would evaluate whether or not to replace them on the board.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.